Position in ILMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,315,694
-$212,510 QoQ
Shares Held
26,900
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $13,530,506 across 6 Diagnostics & Research names. ILMN ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CSTL |
Castle Biosciences Inc
|
255,184 | $6,264,767 | |
| 2 | ILMN |
Illumina, Inc.
This page
|
26,900 | $3,315,694 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,860 | $2,168,895 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
2,830 | $1,358,937 | |
| 5 | XGN |
Exagen Inc.
|
87,402 | $262,206 | |
| 6 | BDSX |
Biodesix Inc
|
11,035 | $160,007 |
All Filings in ILMN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,315,694 | 26,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,528,204 | 26,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,573,687 | 27,100 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||